Doctor Summary Report

30-day summary for Dr. Ananya Iyer, Diabetologist.

Patient

Rohan Mehta, 41

Medication

Rybelsus 7 mg · Semaglutide

Reporting period

1969-12-03 → 1970-01-01

Protein floor

120g/day (today 90g)

Weight trajectory vs estimated lean mass retention (30 days)

Total weight change

-3.8 kg

Lean mass change

-0.3 kg

Loss from lean tissue

8%

Adherence log

Rybelsus fasting adherence: 87%

26 of 30 mornings with a clean 30-minute zero-food, zero-water window. 4 misses were early bed tea (days 6, 13, 21, 27).

DateDoseSite
1969-12-285 mgLeft Abdomen
1969-12-215 mgRight Thigh
1969-12-142.5 mgRight Abdomen
1969-12-072.5 mgLeft Arm

4 injections recorded · rotation compliant, no repeat site within 14 days.

Side-effect frequency
Nausea3× · avg 4.0/10
Acidity / Heartburn3× · avg 6.0/10
Constipation2× · avg 4.0/10
Bloating2× · avg 5.0/10
Fatigue1× · avg 4.0/10
DEXA & visceral fat clinical notes

DEXA visceral fat (last scan)

118 cm² → 96 cm²

Appendicular lean mass index

7.4 kg/m²

Waist circumference

102 cm → 94 cm

Lean mass retention is tracking at 92% of total loss coming from fat mass. Protein intake averaged 114g/day against a 1.6 g/kg floor — adequate for a South Asian phenotype with low baseline muscle reserve.

Visceral adiposity falling faster than total weight, consistent with intended cardiometabolic benefit. Recommend repeat DEXA at week 12 and continued twice-weekly resistance training.

Predominant GI complaint is acidity/heartburn, clustering in the first 48 hours after dose escalation; managed with cold skimmed milk, jeera water and earlier dinners.

Generated by GLP-1 Companion India · patient-reported data, not a diagnostic record. Shareable on WhatsApp or printable on A4.